Skip to main content
. 2018 Aug 3;11:272. doi: 10.3389/fnmol.2018.00272

Figure 6.

Figure 6

Secreted IL-6 expression post a 6-h treatment is significantly altered following TLR4 activation. (A) Cell associated astrocyte expression of IL-6 in WT (n = 6/group) and FMR1 KO (n = 6/group) astrocyte cell cultures grown for 7 days in vitro. The culture was treated with LPS (10 μg/mL), exogenous TNC (10 μg/mL) and LPS-RS (10 μg/mL) for 6 h prior to collection. Representative bands were normalized to the total protein and expressed as a percentage of the average IL-6 in the WT group. (B) Extracellular astrocyte expression of secreted IL-6 in WT (n = 6/group) and FMR1 KO (n = 6/group) astrocyte cell cultures grown for 7 days in vitro. The culture was treated with LPS (10 μg/mL), exogenous TNC (10 μg/mL) and LPS-RS (10 μg/mL) for 6 h prior to ACM concentration and collection. Representative bands were normalized to the total protein and expressed as a percentage of the average IL-6 in the WT group. Statistical differences denoted with a single asterisk, P < 0.05, a double asterisk, P < 0.01 and with triple asterisk, P < 0.001. (C) Cultured cortical astrocytes co-labeled with DAPI (blue) and anti-IL-6 (red) after 3 days in vitro, following a 6 h treatment. Images were obtained using a 40× objective with a Zeiss Axioimager M2. Scale bars = 50 μm.